Repligen Corp (RGEN)
143.72
+1.96
(+1.38%)
USD |
NASDAQ |
Nov 22, 14:52
Repligen Shareholders Equity (Quarterly): 2.017B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 2.017B |
June 30, 2024 | 1.986B |
March 31, 2024 | 1.971B |
December 31, 2023 | 1.965B |
September 30, 2023 | 1.989B |
June 30, 2023 | 1.971B |
March 31, 2023 | 1.940B |
December 31, 2022 | 1.911B |
September 30, 2022 | 1.835B |
June 30, 2022 | 1.805B |
March 31, 2022 | 1.766B |
December 31, 2021 | 1.750B |
September 30, 2021 | 1.715B |
June 30, 2021 | 1.603B |
March 31, 2021 | 1.556B |
December 31, 2020 | 1.529B |
September 30, 2020 | 1.125B |
June 30, 2020 | 1.100B |
March 31, 2020 | 1.070B |
December 31, 2019 | 1.060B |
September 30, 2019 | 1.045B |
June 30, 2019 | 878.97M |
March 31, 2019 | 625.02M |
December 31, 2018 | 615.57M |
September 30, 2018 | 606.49M |
Date | Value |
---|---|
June 30, 2018 | 598.66M |
March 31, 2018 | 597.18M |
December 31, 2017 | 591.55M |
September 30, 2017 | 576.87M |
June 30, 2017 | 190.94M |
March 31, 2017 | 176.79M |
December 31, 2016 | 168.76M |
September 30, 2016 | 166.52M |
June 30, 2016 | 163.72M |
March 31, 2016 | 128.89M |
December 31, 2015 | 122.75M |
September 30, 2015 | 121.45M |
June 30, 2015 | 118.22M |
March 31, 2015 | 111.93M |
December 31, 2014 | 111.73M |
September 30, 2014 | 114.59M |
June 30, 2014 | 115.56M |
March 31, 2014 | 108.85M |
December 31, 2013 | 103.89M |
September 30, 2013 | 100.16M |
June 30, 2013 | 92.45M |
March 31, 2013 | 87.41M |
December 31, 2012 | 84.12M |
September 30, 2012 | 73.70M |
June 30, 2012 | 68.73M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.060B
Minimum
Dec 2019
2.017B
Maximum
Sep 2024
1.683B
Average
1.786B
Median
Shareholders Equity (Quarterly) Benchmarks
West Pharmaceutical Services Inc | 2.752B |
QuidelOrtho Corp | 3.187B |
Perspective Therapeutics Inc | 328.47M |
Xtant Medical Holdings Inc | 45.72M |
Catheter Precision Inc | 12.83M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.831B |
Total Liabilities (Quarterly) | 813.96M |
Debt to Equity Ratio | 0.2586 |
Current Ratio | 10.44 |
Net Debt Paydown Yield | -0.57% |